These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

10248 related items for PubMed ID: 1823927

  • 1. Differential sensitivities of murine melanocytes and melanoma cells to buthionine sulfoximine and anticancer drugs.
    Thrall BD, Raha GA, Springer DL, Meadows GG.
    Pigment Cell Res; 1991 Dec; 4(5-6):234-9. PubMed ID: 1823927
    [Abstract] [Full Text] [Related]

  • 2. Effect of L-dopa methylester and glutathione depletion on murine B16BL6 melanoma growth in vitro.
    Thrall BD, Meadows GG.
    J Invest Dermatol; 1991 Dec; 97(6):1073-7. PubMed ID: 1748817
    [Abstract] [Full Text] [Related]

  • 3. Selective and synergistic activity of L-S,R-buthionine sulfoximine on malignant melanoma is accompanied by decreased expression of glutathione-S-transferase.
    Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC.
    Pigment Cell Res; 1997 Aug; 10(4):236-49. PubMed ID: 9263331
    [Abstract] [Full Text] [Related]

  • 4. Induction of glutathione content in murine melanocytes after transformation with c-H-ras oncogene.
    Thrall BD, Meadows GG.
    Carcinogenesis; 1991 Jul; 12(7):1319-23. PubMed ID: 1712678
    [Abstract] [Full Text] [Related]

  • 5. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P, Loh SY, Kelland LR, Harrap KR.
    Int J Cancer; 1993 Nov 11; 55(5):848-56. PubMed ID: 8244583
    [Abstract] [Full Text] [Related]

  • 6. Selective toxicity of buthionine sulfoximine (BSO) to melanoma cells in vitro and in vivo.
    Révész L, Edgren MR, Wainson AA.
    Int J Radiat Oncol Biol Phys; 1994 May 15; 29(2):403-6. PubMed ID: 8195041
    [Abstract] [Full Text] [Related]

  • 7. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC, Harris JW.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1171-4. PubMed ID: 3744936
    [Abstract] [Full Text] [Related]

  • 8. In vitro and in vivo comparison between the effects of treatment with adenosine triphosphate and treatment with buthionine sulfoximine on chemosensitization and tumour growth of B16 melanoma.
    Palomares T, Bilbao P, del Olmo M, Castro B, Calle Y, Alonso-Varona A.
    Melanoma Res; 1999 Jun 15; 9(3):233-42. PubMed ID: 10465578
    [Abstract] [Full Text] [Related]

  • 9. Role of cellular glutathione and glutathione S-transferase in the expression of alkylating agent cytotoxicity in human breast cancer cells.
    Chen G, Waxman DJ.
    Biochem Pharmacol; 1994 Mar 15; 47(6):1079-87. PubMed ID: 8147907
    [Abstract] [Full Text] [Related]

  • 10. Mitomycin C sensitivity in human bladder cancer cells: possible role of glutathione and glutathione transferase in resistance.
    Xu BH, Gupta V, Singh SV.
    Arch Biochem Biophys; 1994 Jan 15; 308(1):164-70. PubMed ID: 8311448
    [Abstract] [Full Text] [Related]

  • 11. Sensitivity of human melanoma cells to L-dopa and DL-buthionine (S,R)-sulfoximine.
    Kable EP, Favier D, Parsons PG.
    Cancer Res; 1989 May 01; 49(9):2327-31. PubMed ID: 2706620
    [Abstract] [Full Text] [Related]

  • 12. Exogenous glutathione attenuates the antiproliferative effect of buthionine sulfoximine.
    Kang YJ.
    Toxicology; 1994 Mar 11; 88(1-3):177-89. PubMed ID: 8160199
    [Abstract] [Full Text] [Related]

  • 13. Buthionine sulfoximine enhances glutathione-but attenuates glutamate-stimulated cell proliferation.
    Kang YJ.
    Cell Mol Biol Res; 1995 Mar 11; 41(2):131-6. PubMed ID: 8581064
    [Abstract] [Full Text] [Related]

  • 14. Melanin content and downregulation of glutathione S-transferase contribute to the action of L-buthionine-S-sulfoximine on human melanoma.
    Fruehauf JP, Zonis S, al-Bassam M, Kyshtoobayeva A, Dasgupta C, Milovanovic T, Parker RJ, Buzaid AC.
    Chem Biol Interact; 1998 Apr 24; 111-112():277-305. PubMed ID: 9679561
    [Abstract] [Full Text] [Related]

  • 15. Effect of systemic glutathione depletion by buthionine sulfoximine on sensitivity of murine bladder cancer to cytotoxic agents.
    Lee KE, Mayer RD, Cockett AT.
    Urology; 1989 Dec 24; 34(6):376-80. PubMed ID: 2595883
    [Abstract] [Full Text] [Related]

  • 16. Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells.
    Benathan M, Alvero-Jackson H, Mooy AM, Scaletta C, Frenk E.
    Melanoma Res; 1992 Dec 24; 2(5-6):305-14. PubMed ID: 1337997
    [Abstract] [Full Text] [Related]

  • 17. Effect of buthionine sulfoximine and ethacrynic acid on cytotoxic activity of mitomycin C analogues BMY 25282 and BMY 25067.
    Xu BH, Singh SV.
    Cancer Res; 1992 Dec 01; 52(23):6666-70. PubMed ID: 1423311
    [Abstract] [Full Text] [Related]

  • 18. Combined effects of buthionine sulfoximine and cepharanthine on cytotoxic activity of doxorubicin to multidrug-resistant cells.
    Kisara S, Furusawa S, Murata R, Ogata M, Hikichi N, Takayanagi Y, Sasaki K.
    Oncol Res; 1995 Dec 01; 7(3-4):191-200. PubMed ID: 8555653
    [Abstract] [Full Text] [Related]

  • 19. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 20. Hepsulfam sensitivity in human breast cancer cell lines: the role of glutathione and glutathione S-transferase in resistance.
    Armstrong DK, Gordon GB, Hilton J, Streeper RT, Colvin OM, Davidson NE.
    Cancer Res; 1992 Mar 15; 52(6):1416-21. PubMed ID: 1540950
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 513.